Phase II trial of 5-fluorouracil, folinic acid and recombinant α-2a-interferon in patients with advanced colorectal cancer

A clinical trial regimen modulating 5-fluorouracil (5-FU) with both folinic acid (FA) and recombinant α-2a-interferon (rα.-2a-IFN) was noted to have a response rate of 54% and median survival of 16.3 months (Grem ef a/., J Clin Oncol 1993, 111737–45). Reported herein is a phase II trial performed to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Anti-cancer drugs 1999-07, Vol.10 (6), p.519-524
Hauptverfasser:	Ravandi, Farhad, Rytting, Michael E, Osmon, Carlos, Braud, Edward L, Roach, Ralph W, Edwards, Kimberly, Winn, Rodger, Abbruzzese, James L, Pazdur, Richard
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!